91AV

Introduction

The EFMC | ACSMEDI Medicinal 91AV Frontiers is co-organised as a collaboration between the EFMC, European Federation for Medicinal chemistry and Chemical biology, and ACS MEDI, the division of Medicinal 91AV of the American Chemical Society.

The 2024 programme will include:

• 3 high quality plenary lectures
• 9 sessions on key topics in Medicinal 91AV
• About 18 oral communications selected from the submitted abstracts
• An extensive social programme to maximise your networking opportunities
• A poster session and a commercial exhibition

EFMC-ACSMEDI Medicinal 91AV Frontiers Meeting attracts a highly targeted audience composed of experts, researchers and early career trainees in drug discovery and development, in particular medicinal and synthetic chemists, together with scientists active in the fields of computer assisted drug design, biology, DMPK, pharmacology, and early toxicology.

The 2024 edition is chaired by Prof. Iwan DE ESCH (Vrije Universiteit Amsterdam, The Netherlands).

Deadlines

• Jan 25 2024
  Oral abstracts deadline

  
• Jan 25 2024
  Early bird registration deadline

  
• Feb 23 2024
  Poster abstract deadline

  

Useful links

Venue

Royal Jaarbeurs Utrecht

Royal Jaarbeurs Utrecht, Jaarbeursplein, Utrecht, 3521, Netherlands

Useful links

Committee

• Iwan De Esch Vrije Universiteit Amsterdam, Netherlands

---

Organised by

EFMC (European Federation for Medicinal chemistry and Chemical biology) and ACSMEDI

Contact information

Nadia De Vrieze
LD Organisation
Contact us by email

---